OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Haematology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID‐19 vaccine‐associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome	106
The hematologic consequences of obesity	89
Association of anticoagulation dose and survival in hospitalized COVID‐19 patients: A retrospective propensity score‐weighted analysis	64
The incidence, complications, and treatment of iron deficiency in pregnancy	45
Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia	40
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies	39
Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus	38
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series	36
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice	31
The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population‐based haematological malignancy re	27
Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies	27
Current understanding and future implications of sepsis‐induced thrombocytopenia	27
Fecal microbiota transfer for refractory intestinal graft‐versus‐host disease — Experience from two German tertiary centers	26
One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab	26
Review of Vitamin B12 deficiency in pregnancy: a diagnosis not to miss as veganism and vegetarianism become more prevalent	25
Prognostic impact and risk factors of cancer‐associated thrombosis events in stage‐IV cancer patients treated with immune checkpoint inhibitors	24
Long‐term follow‐up of patients with venous thromboembolism and COVID‐19: Analysis of risk factors for death and major bleeding	23
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019	23
Iron chelation therapy	22
Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA	22
Comorbidities in multiple myeloma and implications on survival: A population‐based study	21
Comorbidities and complications in adults with pyruvate kinase deficiency	21